News

Reponsum, Known for Its Fibroid Patient Support App, Raises $25K on Crowdinvesting Platform Republic

Reponsum creates and manages disease-specific, patient knowledge and community building apps in collaboration with pharmaceutical companies. Since entering the market in 2019, the company has launched four platforms, one of them targeting uterine fibroid patients. The company is now giving its users (any anyone else) the opportunity to invest and has started a crowd-investing campaign on Republic aiming to raise $25K, which…

U.K.-based Virtual Fertility Clinic Apricity Appoints Dr. Luca Sabatini as the Company’s New Chief Medical Officer

Virtual Fertility Clinic Apricity has appointed gynaecologist and obstetrician Dr. Luca Sabatini as the company’s new Chief Medical Officer. Dr. Sabatini will work alongside the founders to help implement Apricity’s clinical strategy. Apricity wants to address some of the greatest challenges in fertility through technology. The appointment of Dr. Sabatini comes as Apricity experiences rapid growth, with an expansion into Spain planned…

Social Networking App Peanut Launches New Communities for Women Going through Menopause

Peanut, the social networking app popular among new moms, has announced new features and plans to add support for women going through menopause. The company is launching a new community for menopause, perimenopause and postmenopause. Women who join the Peanut Menopause community can join discussion groups to ask questions and get advice, or join live audio conversations in “Peanut Pods”, the app’s…

Period Tracking App Flo Raises a $50M Series B to Invest in Product Development and Accelerate Growth

The company behind Flo, the app for period and cycle tracking, today announced it closed $50M in a Series B financing, bringing the total capital raised to $65M and company valuation to $800M. VNV Global and Target Global led the round. Flo will use the latest funding to enhance personalization and provide users with advanced cycle insights and symptom patterns to help…

Madorra Receives FDA Breakthrough Device Designation Status for the Treatment of Vulvovaginal Atrophy

Vulvovaginal Atrophy (VVA) is a condition that results from a decrease in the body’s estrogen levels. Symptoms of VVA can include vaginal soreness, irritation, and pain. Research has indicated that the condition affects at least half of all post-menopausal women and breast cancer survivors, many of whom often report substantive reductions in quality of life. The condition may be widely underdiagnosed and undertreated. Symptoms…

Mae Raises a $1.3M Pre-Seed Round to Combat Health Inequities for Black Expectant Mothers

Poor maternal health outcomes take an enormous physical and emotional toll on women and their families. They also add billions in costs to the U.S. healthcare system each year. The U.S. has seen a rise in maternal deaths in recent years, 60% of which are deemed to be avoidable. While rigorous evidence shows that continuous pregnancy support, symptom education and screening, and…

Femtech Pioneer Elvie Adds New Funds Bringing its Series C to £70M

After announcing its Series C this past July, U.K.-based femtech company Elvie has now added to the round bringing the total raised to £70M. The new funds come from the co-founders of Blume Equity, as well as existing investors IPGL, Hiro Capital and Westerly Winds. The previously announced Series C was led by BGF, Blackrock and Octopus Ventures. The company plans to…

SimpliFed Raises a $500K Pre-Seed Round to Revolutionize Infant Nutrition

SimpliFed, a company dedicated to revolutionizing infant nutrition via their virtual lactation and baby feeding support platform, has raised a $500K pre-seed round. The round was led by Third Culture Capital (3CC). The funds, which were raised while SimpliFed’s founder and CEO Andrea Ippolito was pregnant with her second child, will be used to further implement their telehealth platform and share their…